Lobbying client
ZAMBON USA
Clinical stage biopharmaceutical company specializing in advanced inhaled therapeutics
Filings
14
Filed by
1
Reported in-house
—
Reported by firms
$224,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2022
Filings
14 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination (No Activity) 4th Quarter 2022
|
THE KPM GROUP DC LLC | $20,000 reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2022
|
THE KPM GROUP DC LLC | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2022
|
THE KPM GROUP DC LLC | $20,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2022
|
THE KPM GROUP DC LLC | $20,000 reported |
|
1st Quarter - Report 1st Quarter 2022
|
THE KPM GROUP DC LLC | $20,000 reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2021
|
THE KPM GROUP DC LLC | $20,000 reported |
|
3rd Quarter - Report 3rd Quarter 2021
|
THE KPM GROUP DC LLC | $20,000 reported |
|
2nd Quarter - Report 2nd Quarter 2021
|
THE KPM GROUP DC LLC | $24,000 reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2021
|
THE KPM GROUP DC LLC | $20,000 reported |
|
4th Quarter - Report 4th Quarter 2020
|
THE KPM GROUP DC LLC | $20,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE KPM GROUP DC LLC | 12 | $224,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 5 |
| Pharmacy | PHA | 5 |
| Veterans | VET | 2 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.